Viewpoint

DOI: 10.4244/EIJ-D-24-00335

Recyclable and contaminated waste from cardiac procedures: a call to action for a sustainable catheterisation laboratory and operating theatre

Haitham Amin1, MD, FSCAI, FACC, FRCPC; Nooraldaem Yousif1, MD, FRCP, FESC, FACC; Thomas F. Lüscher2,3,4, MD, FRCP, FESC, FACC

Globally, healthcare produces 4% to 5% of the greenhouse gas (GHG) emissions, with a predicted 3-fold increase by 20501. The exponential growth of medical waste contributes to global carbon emissions and poses a significant challenge to environmental sustainability2. Hospitals contribute disproportionately to a substantial carbon footprint, especially in energy intensive areas such as radiology suites, operating rooms, and cardiac catheterisation laboratories (CCLs). The number of cardiac procedures worldwide is increasing, with expanding medical facilities to cater for a growing population. Scarce attention has been given to quantifying and reducing waste from CCLs and cardiac operating theatres (COTs) to help lower the carbon footprint3.

Our CCLs and COTs have a routine waste management protocol in place: all contaminated waste gets collected in designated “yellow” bags, gets shredded, autoclaved, and then placed in disposal bags that go to landfills. Incineration of contaminated waste is another disposal route. Non-contaminated waste including paper, plastics, and cardboard boxes (packaging from balloon catheters, stents, guides etc.) are collected in “green” bags. All this potentially recyclable waste goes to landfills due to the lack of...

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 20 Number 16
Aug 19, 2024
Volume 20 Number 16
View full issue


Key metrics

Suggested by Cory

10.4244/EIJV10I4A71 Aug 19, 2014
Innovations: resetting our thinking to solve problems
Serruys PW
free

10.4244/EIJV9I2A28 Jun 28, 2013
Numbers needed to treat (lives!) and numbers needed to save (money)
Ribichini F et al
free

Editorial

10.4244/EIJ-E-25-00023 May 21, 2025
DAPT de-escalation post-ACS: a new rule or just a new option? Lessons from the 4D-ACS trial
Cuisset T and Cayla G
free

Editorial

10.4244/EIJ-E-24-00067 Jan 20, 2025
Myval transcatheter heart valve system: a new TAVI contender and remaining uncertainties
Windecker S and Tomii D
free
Trending articles
224.5

State-of-the-Art Review

10.4244/EIJ-D-21-00426 Dec 3, 2021
Myocardial infarction with non-obstructive coronary artery disease
Lindahl B et al
free
172.9

Focus article

10.4244/EIJY19M08_01 Jan 17, 2020
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update
Glikson M et al
free
82.15

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
49.6

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
49.6

Original Research

10.4244/EIJ-D-25-00331 Jul 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
31.1

Expert Review

10.4244/EIJ-D-24-00535 May 5, 2025
Catheter-based techniques for pulmonary embolism treatment
Costa F et al
30.4

Clinical Research

10.4244/EIJ-D-21-00363 Jan 28, 2022
Membranous septum morphology and risk of conduction abnormalities after transcatheter aortic valve implantation
Jørgensen T et al
free
23.7

Expert review

10.4244/EIJ-D-18-01180 Feb 20, 2020
Technical aspects in coronary sinus Reducer implantation
Giannini F et al
free
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved